Clinical trial
A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants With Chronic Hepatitis B Infection (PREVAIL)
NCT05612581 is registered in ClinicalTrials.gov with Vir Biotechnology, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Platform Study Evaluating the Efficacy and Safety of Investigational Therapies in Participants With Chronic Hepatitis B Infection (PREVAIL)
- Lead sponsor
- Vir Biotechnology, Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 10, 2023
- Completion date
- August 19, 2025
- Enrollment
- 33 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.